Related Experiment Video

Updated: Sep 30, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Cytotoxic therapy of gastroenteropancreatic (GEP) tumors

K N Syrigos1, D Sitara, E Georgiou

  • 13rd Department of Medicine, Sotiria General Hospital, Athens Medical School, Greece. knsyrigos@usa.net

Anticancer Research
|August 10, 2002
PubMed

Insights

Chemotherapy offers some benefit for neuroendocrine pancreatic tumors (NPTs), but has minimal effect on metastatic carcinoid tumors (MCTs). Challenges in interpreting treatment efficacy persist due to study limitations.

Area of Science:

  • Oncology
  • Gastroenterology
  • Endocrinology

Background:

  • Neuroendocrine gut and pancreatic tumors (GEP) present diagnostic and therapeutic challenges.
  • Disseminated GEP tumors have a poor prognosis despite slow growth.
  • Current therapies focus on symptom control and tumor proliferation management.

Purpose of the Study:

  • To evaluate the role of chemotherapy in managing GEP tumors.
  • To clarify the efficacy of cytotoxic therapy in Neuroendocrine Pancreatic Tumors (NPTs) and Metastatic Carcinoid Tumors (MCTs).

Main Methods:

  • Review of existing studies on chemotherapy for GEP tumors.
  • Analysis of treatment outcomes based on tumor type, origin, and differentiation.

Main Results:

  • Chemotherapy shows a recognized role in managing NPTs.
  • Chemotherapy has a minimal effect on MCTs.
  • Interpretation of cytotoxic therapy efficacy is limited by small study sizes and inconsistencies.

Conclusions:

  • Chemotherapy is a component of NPT management.
  • MCTs show limited response to chemotherapy.
  • Further research with consistent methodologies is needed to accurately assess GEP tumor treatment efficacy.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...